Equities

Darya-Varia Laboratoria Tbk PT

DVLA:JKT

Darya-Varia Laboratoria Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)1,970.00
  • Today's Change-5.00 / -0.25%
  • Shares traded51.50k
  • 1 Year change-28.36%
  • Beta0.1202
Data delayed at least 10 minutes, as of Mar 31 2023 09:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The Company provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The Company also provides Imunped as supplement for kids with Zinc and vitamin C for children.

  • Revenue in IDR (TTM)1.86tn
  • Net income in IDR43.95bn
  • Incorporated1976
  • Employees1.26k
  • Location
    Darya-Varia Laboratoria Tbk PTLantai 8-10, Talavera Office ParkJl. Letjen T.B. Simatupang Kav. 22-26JAKARTA 12430IndonesiaIDN
  • Phone+62 2 122768000
  • Fax+62 2 122768016
  • Websitehttp://www.darya-varia.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Phapros Tbk PT1.17tn28.07bn575.40bn1.51k20.500.76617.140.492433.4233.421,391.04894.110.64121.872.63772,289,800.001.503.512.546.8249.9952.912.346.060.93571.590.5222--11.133.12153.55-25.86-29.64--
Merck Tbk PT1.15tn163.62bn2.15tn393.0013.172.9711.341.88365.22365.222,561.491,621.141.222.168.412,980,644,000.0017.457.2221.6910.9137.7839.0414.269.531.9234.450.0235426.2262.290.565483.11-3.0711.07-2.69
Indofarma Tbk PT2.31tn-223.52bn2.18tn1.18k--6.72--0.9463-72.15-72.15745.51104.921.116.055.691,842,803,000.00-10.77-1.40-23.64-2.791.3517.81-9.68-1.180.9242-3.140.5993--69.1511.62-136,356.00---18.53--
Darya-Varia Laboratoria Tbk PT1.86tn43.95bn2.21tn1.26k50.321.5220.611.1939.2539.251,657.991,300.030.87192.222.661,498,745,000.002.069.982.7213.5252.3353.532.3710.132.18--0.001867.953.895.54-9.47-0.7147-14.9911.89
Kimia Farma Tbk PT10.50tn-180.60bn5.17tn11.51k--0.716519.740.4928-32.52-32.521,890.121,297.920.55982.194.54881,718,000.00-1.011.82-1.643.0033.8536.28-1.802.550.59650.54040.549224.7928.5017.211,613.682.4812.1411.14
Tempo Scan Pacific Tbk PT11.98tn818.70bn6.29tn4.55k7.620.91965.510.5252183.00183.002,679.311,516.931.184.349.262,535,298,000.008.488.3311.5111.4634.2637.207.166.441.85--0.160436.322.434.224.578.96-0.12376.96
Soho Global Health Tbk PT6.89tn325.04bn6.60tn2.41k20.302.6516.780.9574256.10256.105,431.661,963.831.524.704.872,875,966,000.007.15--12.94--18.72--4.72--1.46--0.0108--14.80--219.67------
Data as of Mar 31 2023. Currency figures normalised to Darya-Varia Laboratoria Tbk PT's reporting currency: Indonesian Rupiah IDR
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.